版本:
中国

BRIEF-Acorda Therapeutics presents data from clinical and preclinical trials of CVT-301

Oct 13 Acorda Therapeutics Inc :

* Acorda Therapeutics Inc-presents data from clinical and preclinical trials of CVT-301 for treatment of OFF periods in Parkinson's disease

* Company expects to announce results from its randomized, placebo-controlled Phase 3 trial in Q1 2017 Source text for Eikon: Further company coverage: ;))

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐